OCUCLEAR is an ophthalmic solution (drops) marketed under product number 001. The product route is ophthalmic, dosage form is a solution/drops, and it is not a reference drug. Its marketing status is listed as discontinued. The active ingredient is OXYMETAZOLINE HYDROCHLORIDE at a strength of 0.025%, and no reference standard is indicated.
The FDA submission history for OCUCLEAR includes an original Type 3 new dosage form application (submission 1, approved on 30 May 1986). Subsequent supplemental submissions were approved for manufacturing (CMC) on 20 Aug 1986 (submission 1), 3 Aug 1987 (submission 2), 4 Aug 1987 (submission 4), 30 Mar 1989 (submission 6), 6 Apr 1989 (submission 8), 13 Nov 1996 (submission 13), 14 Jul 1997 (submission 14), 24 Jan 2001 (submission 15), and 6 Jun 2001 (submission 16). A labeling supplement was approved on 24 Aug 1989 (submission 11). All listed submissions have a status of approved (AP).
Regulatory UpdatesSep 27, 2026•1 min read
OCUCLEAR Ophthalmic Solution (0.025% OxyMetazoline HCl) Discontinued
OCUCLEAR ophthalmic drops containing 0.025% oxyMetazoline hydrochloride have been discontinued; FDA records show a series of approved manufacturing and labeling submissions from 1986 to 2001.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating